SoftMedx Healthcare Limited (HKG:0648)
Hong Kong · Delayed Price · Currency is HKD 0.5700
+0.0100 (1.79%)
Sep 2, 2026, 3:29 PM HKT
SoftMedx Healthcare Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 66.55 | 68.24 | 54.64 | 51.34 | 33.77 | 1.7 | |
Revenue Growth | 11.46% | 24.90% | 6.43% | 52.05% | 1887.34% | -82.33% |
Cost of Revenue | 46.01 | 45.65 | 36.24 | 30.22 | 20.03 | 0.91 |
Gross Profit | 20.54 | 22.59 | 18.4 | 21.13 | 13.74 | 0.79 |
Selling, General & Admin | 10.12 | 11.07 | 9.84 | 15.09 | 23.02 | 21.84 |
Operating Expenses | 10.12 | 11.07 | 9.84 | 15.09 | 23.02 | 21.84 |
Operating Income | 10.42 | 11.52 | 8.56 | 6.04 | -9.28 | -21.05 |
Interest Expense | -1.13 | -1.4 | -1.32 | -12.94 | -15.55 | -16.27 |
Interest & Investment Income | 0.04 | 0.07 | 0.19 | 0.36 | 0.04 | 0 |
Currency Exchange Gain (Loss) | - | - | 8.04 | 4.2 | 8.79 | - |
Other Non Operating Income (Expenses) | 1.12 | 2.09 | 1.07 | 2.36 | 0.22 | 7.39 |
EBT Excluding Unusual Items | 10.45 | 12.28 | 16.54 | 0.02 | -15.78 | -29.93 |
Gain (Loss) on Sale of Investments | - | -2.82 | -16.61 | 19.08 | -0.73 | -2.74 |
Gain (Loss) on Sale of Assets | - | - | - | -4.73 | - | 7.95 |
Asset Writedown | - | - | - | - | -0.35 | - |
Other Unusual Items | -0.02 | -0.02 | 328.03 | - | 0.22 | - |
Pretax Income | 10.43 | 9.45 | 327.95 | 14.37 | -16.63 | -24.72 |
Income Tax Expense | 2.19 | 2.5 | 1.64 | 1.86 | 2.59 | - |
Earnings From Continuing Operations | 8.25 | 6.95 | 326.32 | 12.51 | -19.23 | -24.72 |
Net Income to Company | 8.25 | 6.95 | 326.32 | 12.51 | -19.23 | -24.72 |
Minority Interest in Earnings | - | - | - | - | - | -1.56 |
Net Income | 8.25 | 6.95 | 326.32 | 12.51 | -19.23 | -26.28 |
Net Income to Common | 8.25 | 6.95 | 326.32 | 12.51 | -19.23 | -26.28 |
Net Income Growth | -97.54% | -97.87% | 2508.24% | - | - | - |
Shares Outstanding (Basic) | 74 | 29 | 16 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 74 | 29 | 16 | 16 | 16 | 16 |
Shares Change | 354.44% | 77.14% | - | - | - | - |
EPS (Basic) | 0.11 | 0.24 | 20.02 | 0.77 | -1.18 | -1.61 |
EPS (Diluted) | 0.11 | 0.24 | 20.02 | 0.77 | -1.18 | -1.61 |
EPS Growth | -99.46% | -98.80% | 2508.24% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 18.93 | 5.4 | 3.88 | -4.49 | -3.38 | -7.14 |
Free Cash Flow Per Share | 0.26 | 0.19 | 0.24 | -0.28 | -0.21 | -0.44 |
Gross Margin | 30.87% | 33.11% | 33.67% | 41.15% | 40.68% | 46.50% |
Operating Margin | 15.66% | 16.89% | 15.67% | 11.76% | -27.50% | -1238.79% |
Profit Margin | 12.39% | 10.18% | 597.22% | 24.37% | -56.94% | -1546.50% |
Free Cash Flow Margin | 28.44% | 7.91% | 7.10% | -8.75% | -10.00% | -420.36% |
EBITDA | 10.43 | 11.59 | 8.73 | 6.26 | -8.95 | -20.83 |
EBITDA Margin | 15.67% | 16.98% | 15.98% | 12.20% | -26.51% | - |
D&A For EBITDA | 0.01 | 0.06 | 0.17 | 0.23 | 0.33 | 0.21 |
EBIT | 10.42 | 11.52 | 8.56 | 6.04 | -9.28 | -21.05 |
EBIT Margin | 15.66% | 16.89% | 15.67% | 11.76% | -27.50% | - |
Effective Tax Rate | 20.98% | 26.44% | 0.50% | 12.93% | - | - |